These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 28800175)

  • 41. The molecular signature of AML mesenchymal stromal cells reveals candidate genes related to the leukemogenic process.
    Binato R; de Almeida Oliveira NC; Du Rocher B; Abdelhay E
    Cancer Lett; 2015 Dec; 369(1):134-43. PubMed ID: 26279521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Direct confirmation of quiescence of CD34+CD38- leukemia stem cell populations using single cell culture, their molecular signature and clinicopathological implications.
    Won EJ; Kim HR; Park RY; Choi SY; Shin JH; Suh SP; Ryang DW; Szardenings M; Shin MG
    BMC Cancer; 2015 Apr; 15():217. PubMed ID: 25881148
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.
    Williams MS; Basma NJ; Amaral FMR; Wiseman DH; Somervaille TCP
    BMC Cancer; 2021 Oct; 21(1):1153. PubMed ID: 34711181
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors.
    Venton G; Pérez-Alea M; Baier C; Fournet G; Quash G; Labiad Y; Martin G; Sanderson F; Poullin P; Suchon P; Farnault L; Nguyen C; Brunet C; Ceylan I; Costello RT
    Blood Cancer J; 2016 Sep; 6(9):e469. PubMed ID: 27611922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
    Al-Mawali A; Gillis D; Lewis I
    J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mesenchymal stromal cells contribute to quiescence of therapy-resistant leukemic cells in acute myeloid leukemia.
    Wang W; Bochtler T; Wuchter P; Manta L; He H; Eckstein V; Ho AD; Lutz C
    Eur J Haematol; 2017 Nov; 99(5):392-398. PubMed ID: 28800175
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic targeting of leukemic stem cells in acute myeloid leukemia - the biological background for possible strategies.
    Bruserud Ø; Aasebø E; Hernandez-Valladares M; Tsykunova G; Reikvam H
    Expert Opin Drug Discov; 2017 Oct; 12(10):1053-1065. PubMed ID: 28748730
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia.
    Bolandi SM; Pakjoo M; Beigi P; Kiani M; Allahgholipour A; Goudarzi N; Khorashad JS; Eiring AM
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831055
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic and therapeutic role of CLEC12A in acute myeloid leukemia.
    Morsink LM; Walter RB; Ossenkoppele GJ
    Blood Rev; 2019 Mar; 34():26-33. PubMed ID: 30401586
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A.
    Grandits AM; Wieser R
    Exp Hematol; 2021 Jul; 99():1-11. PubMed ID: 34029637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased CA 125 serum levels in patients with advanced acute leukemia with serosal involvement.
    Camera A; Villa MR; Rocco S; De Novellis T; Costantini S; Pezzullo L; Lucania A; Mariano A; Macchia V; Rotoli B
    Cancer; 2000 Jan; 88(1):75-8. PubMed ID: 10618608
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The golden age for patients in their golden years: The progressive upheaval of age and the treatment of newly-diagnosed acute myeloid leukemia.
    Shallis RM; Boddu PC; Bewersdorf JP; Zeidan AM
    Blood Rev; 2020 Mar; 40():100639. PubMed ID: 31761380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuroleukemiosis: Diagnosis and management.
    Mau C; Ghali MGZ; Styler M; Malysz J; Specht CS; Rizk E
    Clin Neurol Neurosurg; 2019 Sep; 184():105340. PubMed ID: 31387077
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.